Joined June 2025
73 Photos and videos
@CellTolerance continues to expand. Univerzitná nemocnica Martin in Slovakia joins the multiple centers worldwide performing this examination routinely, bringing precision gut diagnostics to patients navigating food-triggered symptoms. @imedex_cz #foodintolerance #GITwitter
1
17
Standard diagnostics often fail #IBS patients. The @CellTolerance test offers a more clinical approach to relief. Bridge the gap between testing & patient relief at an exclusive workshop with Prof. Jost Langhorst, MD. Reserve your spot: hubs.la/Q04jYph90 #GITwitter
2
28
On #WDHD2026, established by @WorldGastroOrg, we're emphasizing @CellTolerance 's vital role in #IBS management. Millions are affected by persistent food-related digestive issues & are looking for a new approach to reclaiming their #digestivehealth. hubs.la/Q04hyKVw0
2
32
#ICYMI @CellTolerance is officially expanding into the United Arab Emirates & Turkey! With #IBS & food intolerances impacting up to 27% of the population in these markets, our precision diagnostics are ready to make a major impact. hubs.ly/Q04hyR_L0 #GITwitter #Cellvizio
1
28
@CellTolerance is coming to the Middle East! Following regulatory clearances in the UAE and Turkey, we confirm our first commercial installation in a region where #IBS & #foodintolerances affect up to 27% of the population on average. hubs.la/Q04hnzJS0 #Cellvizio #GITwitter
1
34
Inspired by a memorable patient story, Dr. Monica Rusticeanu reflects on the impact of the @CellTolerance test, stating it made her "think openly about a lot of possibilities." Discover how it’s advancing #IBS patient care: hubs.la/Q04h7Y1z0 #GITwitter
1
31
Did you know? A staggering 1 in 3 IBS patients (33%) feel completely or somewhat out of control of their symptoms. Optimize #IBS patient care by integrating the @CellTolerance program to improve the mgmt & comprehension of IBS in your practice. hubs.la/Q04gD_2L0 #GITwitter
1
36
New #DDW2026 data marks a pivotal moment for patients struggling w/ unexplained gut issues. @CellTolerance CLE (#Cellvizio) gives physicians real-time, cellular-level visualization of the intestinal mucosa that conventional tests often miss. hubs.la/Q04ftw8M0 #GITwitter

1
64
Thank you to all physicians who joined us at the @CellTolerance dinner at DDW! Great discussions, compelling data, & experts aligned on addressing this huge patient population. Big thanks to @LindaNguyenMD & @SeanSpencer for their insights. The future of #CellTolerance is here!
1
56
@CellTolerance is transforming #IBS patient care. See the latest abstracts on the new standard of #digestivehealth at #DDW2026 in Chicago! @DDWMeeting #CellTolerance #GutHealth #GITwitter #FoodIntolerance
1
55
Major clinical momentum for #Cellvizio at #DDW2026! 10 new abstracts spanning #pancreaticcysts, IBD assessment, gastric disease, and #foodintolerance, Read more: hubs.la/Q04dShqv0 @DDWMeeting @CellTolerance #GITwitter
1
2
127
#ICYMI: #CellTolerance is live at @Clinica_Teknon! Huge thanks to Dr. Gherzon Casanova Rimer & team. #CellTolerance powered by #Cellvizio, helps physicians identify food triggers for personalized #IBS care. Global adoption is growing: patients deserve precise answers! #GITwitter
2
17
CellTolerance retweeted
🎙️ 3 Questions à Sacha Loiseau (Mauna Kea Technologies) @sachaloiseau, Président Directeur Général de @maunakeatech, revient sur le renouveau de la société, les raisons de l'excellente dynamique commerciale aux U.S. et les bonnes performances de Cell Tolerance.
3
4
227
Standard diagnostics often fail #IBS patients. The @CellTolerance test offers a more clinical approach to relief. Bridge the gap between testing & patient relief at an exclusive workshop with Prof. Jost Langhorst, MD. Reserve your spot: hubs.la/Q04dq4W50 #GITwitter
1
20
Many IBS-related #foodintolerance tests miss the real cause, often leading to ongoing symptoms & frustration. @CellTolerance can help relieve #IBS symptoms through a proven, multi-disciplinary approach with fast results. hubs.la/Q04dc_My0 #IBSAwarenessMonth #GITwitter
1
23
Today is #WorldIBSDay2026. #IBS and the symptoms are real. New multi-disciplinary approaches like multi-disciplinary approaches like @celltolerance powered by #Cellvizio, are helping physicians finally see what's happening at the gut level. hubs.ly/Q04crGXt0 #GITwitter
2
31
First @CellTolerance cases at @Clinica_Teknon! Powered by #Cellvizio, #CellTolerance helps clinicians identify food triggers for precise, individualized #IBS care. Thrilled that patients in Spain now have access to this revolutionary test! #GITwitter #guthealth
1
2
76
Our reported Q1 2026 results reflect the growing global adoption of #Cellvizio and the impact of our @CellTolerance investment. This highlights Cellvizio’s growing role as a standard of care in #pancreaticcyst evaluation & patient mngmt. hubs.la/Q04cbHBg0 $ALMKT
1
2
108
IBS affects up to 12% of the US population yet diagnosis can take years. Real-time confocal mucosal imaging is changing how we understand and manage functional GI conditions. Visit: hubs.la/Q04bCH6M0 to learn more. #IBSAwarenessMonth #GITwitter
1
19
First @CellTolerance exams at @MedUniGraz! #Cellvizio visualized real-time mucosal responses to a wheat challenge in an EoE patient. Real-time insights into mucosal barrier impairment aim to provide patients with answers & relief. #GITwitter
1
19